The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity

被引:134
|
作者
Greenwald, J
Le, V
Butler, SL
Bushman, FD
Choe, S
机构
[1] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA
关键词
D O I
10.1021/bi9907173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Replication of HIV-1 requires the covalent integration of the viral cDNA into the host chromosomal DNA directed by the virus-encoded integrase protein. Here we explore the importance of a protein surface loop near the integrase active site using protein engineering and X-ray crystallography. We have redetermined the structure of the integrase catalytic domain (residues 50-212) using an independent phase set at 1.7 Angstrom resolution. The structure extends helix alpha 4 on its N-terminal side (residues 149-154), thus defining the position of the three conserved active site residues. Evident in this and in previous structures is a conformationally flexible loop composed of residues 141-148. To probe the role of flexibility in this loop, we replaced Gly 140 and Gly 149, residues that appear to act as conformational hinges, with Ala residues. X-ray structures of the catalytic domain mutants G149A and G140A/G149A show further rigidity of alpha 4 and the adjoining loop. Activity assays in vitro revealed that these mutants are impaired in catalysis. The DNA binding affinity, however, is minimally affected by these mutants as assayed by UV cross-linking. We propose that the conformational flexibility of this active site loop: is important for a postbinding catalytic step.
引用
收藏
页码:8892 / 8898
页数:7
相关论文
共 50 条
  • [21] Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium
    Goldgur, Y
    Dyda, F
    Hickman, AB
    Jenkins, TM
    Craigie, R
    Davies, DR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9150 - 9154
  • [22] Identification of a monoclonal antibody binding site of HIV-1 integrase
    Yi, JZ
    Skalka, AM
    FASEB JOURNAL, 1999, 13 (07): : A1503 - A1503
  • [23] Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
    Fenwick, Craig
    Amad, Ma'an
    Bailey, Murray D.
    Bethell, Richard
    Boes, Michael
    Bonneau, Pierre
    Cordingley, Michael
    Coulombe, Rene
    Duan, Jianmin
    Edwards, Paul
    Fader, Lee D.
    Faucher, Anne-Marie
    Garneau, Michel
    Jakalian, Araz
    Kawai, Stephen
    Lamorte, Louie
    LaPlante, Steven
    Luo, Laibin
    Mason, Steve
    Poupart, Marc-Andre
    Rioux, Nathalie
    Schroeder, Patricia
    Simoneau, Bruno
    Tremblay, Sonia
    Tsantrizos, Youla
    Witvrouw, Myriam
    Yoakim, Christiane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3233 - 3244
  • [24] The active site of HIV-1 protease
    Mager, PP
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 348 - 353
  • [25] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [26] Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae
    Parissi, V
    Caumont, AB
    de Soultrait, VR
    Calmels, C
    Pichuantes, S
    Litvak, S
    Dupont, CH
    JOURNAL OF MOLECULAR BIOLOGY, 2000, 295 (04) : 755 - 765
  • [27] Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants
    Lee, MC
    Deng, JX
    Briggs, JM
    Duan, Y
    BIOPHYSICAL JOURNAL, 2005, 88 (05) : 3133 - 3146
  • [28] Activity of recombinant HIV-1 integrase on mini-HIV DNA
    Cherepanov, P
    Surratt, D
    Toelen, J
    Pluymers, W
    Griffith, J
    De Clercq, E
    Debyser, Z
    NUCLEIC ACIDS RESEARCH, 1999, 27 (10) : 2202 - 2210
  • [29] HIV-1 integrase inhibitor interactions at the active site: Prediction of binding modes unaffected by crystal packing
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (25) : 6136 - 6137
  • [30] HIV-1 integrase inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (04) : 170 - 170